Did Rubedo’s experimental drug really make skin two years younger? Phase 1b data reveal a surprising signal
Rubedo's RLS-1496 reduces measured skin epigenetic age by 2.1 years in early research, but clinical benefits remain to be proven.
Pharma & Biotech
Medical Devices & Diagnostics
Vinci Pharmaceuticals wants to replace repeated eye injections with an implant. Can $8m bring EPIPLANT into the clinic?
Vinci Pharmaceuticals secures over $8 million to advance EPIPLANT retinal drug delivery toward human trials in 2027. See what comes next.
Pharma & Biotech
Stoke Therapeutics boosts a protein linked to inherited blindness, but can STK-002 save vision?
Stoke Therapeutics reports STK-002 OPA1 protein gains as Phase 1 OSPREY advances. Examine the evidence, safety questions and 2027 readout.
Pharma & Biotech
Catalent is entering unit-dose OTC gels with Mantra. Can medicine in a pouch challenge pills?
Catalent will manufacture Mantra's single-serve OTC gels for sleep, pain and menstrual relief. See what the deal means for drug delivery and supply.
Pharma & Biotech
Can TG Therapeutics establish BRIUMVI superiority without a head-to-head clinical trial?
A peer-reviewed five-year indirect comparison associates BRIUMVI with lower modeled disability progression risk than ocrelizumab and ofatumumab. The findings support TG Therapeutics' commercial evidence strategy but cannot establish head-to-head superiority.
Pharma & Biotech
LIVMARLI cuts bile acids 70% in Phase 3. Can Mirum turn its biliary atresia breakthrough into FDA approval?
Mirum's LIVMARLI meets its Phase 3 itch endpoint and cuts bile acids, supporting a planned 2027 FDA filing for rare liver diseases.
Pharma & Biotech
ANB033 shows significant protection against gluten damage in First Tracks Biotherapeutics’ celiac disease trial
Explore how First Tracks Biotherapeutics' ANB033 reduced gluten-induced intestinal damage and symptoms in a Phase 1b celiac disease trial.
Pharma & Biotech
World ADC 2026 highlights Invenra’s approach to HER2 and HER3 targeting
Invenra launches 52 Views of Cancer and expands trispecific ADC research targeting HER2 and HER3. See the science and development challenges.
Medical Devices & Diagnostics
Fujifilm’s new pathology AI can classify tissue changes, but is it ready for cancer diagnosis?
Fujifilm launches Synapse Pathology v3.0 with 50-plus upgrades, AI integration and a research-only foundation model for tissue analysis.
Medical Devices & Diagnostics
Can Insulet’s new diabetes data platform improve time in range and patient engagement?
Insulet launches Omnipod Discover across the US after 15,000 users adopt the platform. Examine its glucose data, clinical evidence and impact.